PT3752129T - Composição multiuso de torasemida - Google Patents

Composição multiuso de torasemida

Info

Publication number
PT3752129T
PT3752129T PT197107501T PT19710750T PT3752129T PT 3752129 T PT3752129 T PT 3752129T PT 197107501 T PT197107501 T PT 197107501T PT 19710750 T PT19710750 T PT 19710750T PT 3752129 T PT3752129 T PT 3752129T
Authority
PT
Portugal
Prior art keywords
torasemide
composition
torasemide composition
use torasemide
Prior art date
Application number
PT197107501T
Other languages
English (en)
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Publication of PT3752129T publication Critical patent/PT3752129T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT197107501T 2018-02-16 2019-02-15 Composição multiuso de torasemida PT3752129T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1851353A FR3077984B1 (fr) 2018-02-16 2018-02-16 Composition multiusage de torasemide

Publications (1)

Publication Number Publication Date
PT3752129T true PT3752129T (pt) 2022-02-03

Family

ID=62167516

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197107501T PT3752129T (pt) 2018-02-16 2019-02-15 Composição multiuso de torasemida

Country Status (18)

Country Link
US (1) US11337921B2 (pt)
EP (1) EP3752129B1 (pt)
JP (1) JP7254101B2 (pt)
KR (1) KR20200121835A (pt)
CN (1) CN111741745B (pt)
AU (1) AU2019221126B2 (pt)
BR (1) BR112020016597B1 (pt)
CA (1) CA3090570A1 (pt)
DK (1) DK3752129T3 (pt)
ES (1) ES2907143T3 (pt)
FR (1) FR3077984B1 (pt)
HR (1) HRP20220151T1 (pt)
HU (1) HUE057602T2 (pt)
PL (1) PL3752129T3 (pt)
PT (1) PT3752129T (pt)
RU (1) RU2020130402A (pt)
SI (1) SI3752129T1 (pt)
WO (1) WO2019158873A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3906020A1 (en) * 2019-01-04 2021-11-10 SQ Innovation AG Pharmaceutical compositions of torsemide and uses thereof
CN114376969A (zh) * 2020-10-19 2022-04-22 南京济群医药科技股份有限公司 一种托拉塞米注射液及其制备方法
CN112168776B (zh) * 2020-10-30 2022-05-03 康普药业股份有限公司 一种低杂质高稳定的托拉塞米注射液和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
EP1895983A2 (en) * 2005-05-27 2008-03-12 Panacea Biotec Ltd. Injectable compositions and process for preparation of such compositions
CN101007003A (zh) * 2007-02-01 2007-08-01 扬子江药业集团南京海陵药业有限公司 一种稳定的托拉塞米注射液及其制备方法
CN102512360B (zh) * 2011-12-09 2014-06-25 天津市汉康医药生物技术有限公司 稳定安全的供注射用托拉塞米药物组合物
BR112014028602B1 (pt) * 2012-05-18 2023-10-24 Luoda Pharma Limited Formulação líquida não aquosa oralmente biodisponível para administração oral
MX2017015670A (es) * 2015-06-08 2018-08-15 Dermarc LLC Composicion terapeutica.

Also Published As

Publication number Publication date
JP7254101B2 (ja) 2023-04-07
EP3752129A1 (fr) 2020-12-23
FR3077984A1 (fr) 2019-08-23
HUE057602T2 (hu) 2022-06-28
WO2019158873A1 (fr) 2019-08-22
EP3752129B1 (fr) 2021-11-24
JP2021514393A (ja) 2021-06-10
AU2019221126B2 (en) 2024-06-13
BR112020016597A2 (pt) 2020-12-15
CN111741745A (zh) 2020-10-02
FR3077984B1 (fr) 2020-02-21
HRP20220151T1 (hr) 2022-04-15
CN111741745B (zh) 2024-03-26
BR112020016597B1 (pt) 2022-11-16
RU2020130402A (ru) 2022-03-16
KR20200121835A (ko) 2020-10-26
US20200375898A1 (en) 2020-12-03
ES2907143T3 (es) 2022-04-22
AU2019221126A1 (en) 2020-08-27
US11337921B2 (en) 2022-05-24
DK3752129T3 (da) 2022-02-21
PL3752129T3 (pl) 2022-03-21
SI3752129T1 (sl) 2022-04-29
CA3090570A1 (fr) 2019-08-22

Similar Documents

Publication Publication Date Title
ZA202002723B (en) Composition
GB201703455D0 (en) Composition
GB2562466B (en) Composition
GB201719139D0 (en) Composition
GB201707238D0 (en) Composition
GB201700504D0 (en) Composition
HUE057602T2 (hu) Többcélú toraszemid-készítmény
GB201713636D0 (en) Composition
GB201712151D0 (en) Composition
EP3675653C0 (fr) Composition antimycotoxine
GB201721674D0 (en) Composition
GB201709905D0 (en) Composition
GB201702833D0 (en) Composition
GB2579152B (en) Insulation composition
GB201816988D0 (en) Composition
LT3576546T (lt) Probiotikų kompozicija
GB201718871D0 (en) Composition
GB201715135D0 (en) Composition
GB201713246D0 (en) Insulation composition
GB201711446D0 (en) Composition
GB201707920D0 (en) Composition
GB201703457D0 (en) Composition
ZA201904385B (en) Composition
HUE063642T2 (hu) Probiotikus készítmény
GB201720891D0 (en) New composition